🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

CAVA shares price target raised on strong Q1 EBITDA

EditorNatashya Angelica
Published 29/05/2024, 17:58
CAVA
-

On Wednesday, CAVA Group Inc (NYSE:CAVA) received a positive assessment from Jefferies, as the firm raised its price target on the stock to $94 from $72, while reiterating a Buy rating. The adjustment follows CAVA's reported first-quarter EBITDA of $33.3 million, surpassing the consensus estimate of $22.5 million. This outperformance was attributed to better-than-expected same-store sales (SSS) and restaurant-level margin (RLM) growth.

The company has also increased its full-year 2024 guidance for both SSS and RLM, indicating a potential acceleration in SSS in the coming months. Expected to contribute to this uptrend are the continued strong demand, the introduction of a new steak product, and an overhaul of the loyalty program. Notably, the anticipated benefits from the loyalty program revamp are not yet factored into the full-year guidance.

Despite anticipating a year-over-year moderation in margins, which includes the impact of beef prices, Jefferies maintains a positive outlook on CAVA's operational opportunities. The firm believes these opportunities will become more apparent and materialize over time. As a result of these factors, Jefferies has increased its estimates for the company.

In summary, Jefferies' updated analysis reflects a bullish stance on CAVA, underpinned by solid first-quarter performance and promising initiatives that could drive further growth in the near term. The raised price target to $94 is indicative of the firm's confidence in the stock's potential.

InvestingPro Insights

In light of Jefferies’ optimistic outlook on CAVA Group Inc, real-time data from InvestingPro supports the company's strong performance trajectory. With a market capitalization of $9.39 billion and a notable revenue growth of 29.01% in the last twelve months as of Q1 2024, CAVA is showing robust financial health.

The company's impressive one-year price total return of 88.21% echoes Jefferies' positive assessment and the stock's potential, as it trades near its 52-week high at 98.26% of the peak value. Moreover, CAVA's strategic initiatives are mirrored by a substantial six-month price total return of 142.35%, highlighting the market's favorable response to its operational advancements.

InvestingPro Tips suggest that while CAVA is trading at high valuation multiples, such as a Price/Earnings (P/E) ratio of 251.85 and a Price/Book (P/B) ratio of 16.6, the company's strong returns over the past year and recent months may justify these premium valuations. Analysts also predict that CAVA will be profitable this year, a sentiment supported by a profitable performance in the last twelve months.

For investors seeking a deeper analysis, InvestingPro offers additional tips on CAVA, which can be accessed with a special promo code. Use PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and discover the full range of insights and metrics that can help inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.